Surfen
Names
[ CAS No. ]:
5424-37-3
[ Name ]:
Surfen
[Synonym ]:
Aminoquincarbamide dihydrochloride
Aminoquinuride hydrochloride
Biological Activity
[Description]:
Surfen dihydrochloride is a potent HS (heparan sulfate) antagonist. Surfen binds to glycosaminoglycans. Surfen neutralizes the anticoagulant activity of both unfractionated and low molecular weight heparins. Surfen affects sulfation of heparin and inhibits degradation by heparin lyases. Surfen inhibits FGF2 binding and signaling. Surfen inhibits cell attachment, and virus infection[1].
[Related Catalog]:
[Target]
FGFR2:5 μM (IC50)
HSV-1
[References]
Chemical & Physical Properties
[ Boiling Point ]:
587.2ºC at 760 mmHg
[ Molecular Formula ]:
C21H22Cl2N6O
[ Molecular Weight ]:
445.34
[ Flash Point ]:
308.9ºC
[ Exact Mass ]:
408.14700
[ PSA ]:
118.95000
[ LogP ]:
6.31860
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- YS1950300
- CHEMICAL NAME :
- Urea, 1,3-bis(4-amino-2-methyl-6-quinolyl)-, dihydrochloride
- CAS REGISTRY NUMBER :
- 5424-37-3
- LAST UPDATED :
- 198308
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C21-H20-N6-O.2Cl-H
- MOLECULAR WEIGHT :
- 445.39
- WISWESSER LINE NOTATION :
- T66 BNJ C1 EZ HMVM- HT66 BNJ C1 EZ &GH 2
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 312 mg/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes
- REFERENCE :
- ANTCAO Antibiotics and Chemotherapy (Washington, DC). (Washington, DC) V.1-12, 1951-62. For publisher information, see CLMEA3. Volume(issue)/page/year: 2,581,1952
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 16300 ug/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes
- REFERENCE :
- ANTCAO Antibiotics and Chemotherapy (Washington, DC). (Washington, DC) V.1-12, 1951-62. For publisher information, see CLMEA3. Volume(issue)/page/year: 2,581,1952